glp 1 is tirzepatide Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Semaglutide & Tirzepatide Weight Loss
Description
Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials
.webp)
Any blood pressure reduction should be viewed as a beneficial additional effect rather than the primary therapeutic goal
The efficacy of the new pharmacotherapies will allow clinicians to treat obesity towards individualised treatment targets, similar to what is happening with other chronic diseases such as T2D or dyslipidaemia
J Neurosci (2012) 32:481220
